These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2368366

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D, Cotoi S.
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Demonstration of an additive antihypertensive effect of prazosin and polythiazide in out-patient.
    Kuokkanen K, Mattila MJ.
    Curr Ther Res Clin Exp; 1975 May; 17(5):431-6. PubMed ID: 805026
    [No Abstract] [Full Text] [Related]

  • 25. [Valley/peak ratio and pressure changes during treatment with fosinopril in hypertensive elderly patients].
    Cicconetti P, Salza MC, Rizzo V, Bianchi A, Capponi L, Marigliano V.
    Clin Ter; 1996 May; 147(7-8):359-64. PubMed ID: 9118617
    [Abstract] [Full Text] [Related]

  • 26. Effects of prolonged administration of metolazone in the treatment of essential hypertension.
    Cangiano JL.
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):745-50. PubMed ID: 827420
    [No Abstract] [Full Text] [Related]

  • 27. Hypertension in the elderly: new and old evidence that treatment may benefit the old.
    Fagard RH.
    J Nephrol; 2009 Dec; 22(5):580-6. PubMed ID: 19809990
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Benefits and risks of combination therapy in hypertension.
    Node K.
    Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 35. A review of hypertension in the elderly.
    Alebiosu CO.
    Niger Postgrad Med J; 2001 Sep; 8(3):150-4. PubMed ID: 11721219
    [Abstract] [Full Text] [Related]

  • 36. [Management of patients with hypertension resistant to treatment].
    Girerd X, Hanon O.
    Rev Prat; 1999 Mar 01; 49(5):527-31. PubMed ID: 10358403
    [Abstract] [Full Text] [Related]

  • 37. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001 Mar 01; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

  • 38. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Matsumoto K.
    Pharmacotherapy; 2009 Sep 01; 29(9):1061-72. PubMed ID: 19698011
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.